Table 3. HPV Test Positive Cases in Sub-Cohorts (Our Clinical Research).
Tumor type | Treatment method | HPV test-positive cases, n (%) |
---|---|---|
Male 37 (42.0)/female 6 (33.3) | ||
Recurrent/metastatic nasopharyngeal cancer in Japanese | Methotrexate, docetaxel or cetuximab (n = 4) | 2 (50) |
Nivolumab (n = 36) | 15 (41.67) | |
BNT162b2 mRNA Vac. + methotrexate, docetaxel or cetuximab (n = 6) | 2 (33.33) | |
mRNA-1273 Vac. + methotrexate, docetaxel or cetuximab (n = 6) | 2 (33.33) | |
BNT162b2 mRNA Vac. + nivolumab (n = 54) | 22 (40.74) | |
mRNA-1273 Vac + nivolumab (n = 0) | 0 |
HPV: human papillomavirus; Vac.: vaccine.